Where I see patients (1)
My reviews
Selected research
- 
							Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis.
							Blood cancer discovery
- 
							Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial.
							Clinical lymphoma, myeloma & leukemia
- 
							Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation.
							Clinical lymphoma, myeloma & leukemia
 
					
				
 
														 
														 
														 
														 
														 
				
					 
				
5.0